Stay updated on Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial page.

Latest updates to the Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has been updated to reflect a new version of the clinical trial study, now focusing on Nivolumab in the treatment of cervical cancer, with significant details about the study's collaborators and the investigational drug's use in combination with chemoradiation.SummaryDifference28%
- Check31 days agoChange DetectedThe page has updated the study timeline to reflect an average duration of 2 years from the start of treatment to study completion, and it has changed the revision number from v2.14.3 to v2.14.4.SummaryDifference1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference2%
- Check95 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Tailored RT & Cisplatin in Cervical Cancer Clinical Trial page.